Smartphone Connectivity Is Here!

We’ve hit a big milestone! it’s been 90 days since the first MiniMed™ 770G system shipped to it’s very first patient. Every day since, our field clinical experts have been working hard at delivering trainings both virtually and in person. From those experiences, we’ve rounded up some of the best practices they’ve shared, specifically those centered around the MiniMedTM Mobile and CareLinkTM Connect Apps. Read more below regarding the best ways to ensure patients stay connected, live more and worry less.

Best Practices:

  • When setting up the MiniMedTM Mobile app, ensure your patient uses their existing CareLinkTM username and password. Need help retrieving this information? Call 24HR Technical Support at 1-800-646-4633.
  • Encourage patients to always keep their MiniMed™ Mobile app open. If they accidentally close the app or their smartphone battery dies, the pump and CGM data will automatically backfill once the app is reopened.
  • In order to avoid compatibility issues, the “automatic updates” feature on your patient’s mobile device’s settings should be turned off. Before updating the device’s software, ensure your patient has accessed the link below to verify which devices are supported:
  • For more information on setting up, using and troubleshooting the MiniMedTM Mobile and CareLinkTM Connect Apps, visit

Ready to learn more? Join us March 3, 2021 for the second session of “The Training Success Kit: A Webinar Series for CPTs” as we discuss the MiniMed 770G System: Apps and Connectivity Insights and take a deep dive into the MiniMedTM Smartphone Apps, the MinMedTM 770G Virtual Pump and other exciting connectivity related updates. Click here to register.

< Return to Diabetes Digest

Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at